Orange Book product · Generic (ANDA)
LANTHANUM CARBONATE
LANTHANUM CARBONATE
At a glance
Jan 27, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 27, 2022
4 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
LANTHANUM CARBONATE
Strength
EQ 1GM BASE
Dosage form
TABLET, CHEWABLE
Route
ORAL
TE code
AB
Application
ANDA 090977
Product number
003
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LANTHANUM CARBONATE
- 2014FOSRENOLBrand (NDA)
NDA 204734 · TAKEDA PHARMS USA
- 2005FOSRENOLBrand (NDA)
NDA 021468 · TAKEDA PHARMS USA
- 2025LANTHANUM CARBONATEGeneric (ANDA)
ANDA 202329 · ALKEM LABS LTD
- 2022LANTHANUM CARBONATEGeneric (ANDA)
ANDA 206868 · INVAGEN PHARMS
- 2017LANTHANUM CARBONATEGeneric (ANDA)
ANDA 090978 · NATCO PHARMA LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
